Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer
S Misra, VC Hascall, RR Markwald… - Frontiers in …, 2015 - frontiersin.org
The glycosaminoglycan hyaluronan (HA), a major component of extracellular matrices, and
cell surface receptors of HA have been proposed to have pivotal roles in cell proliferation …
cell surface receptors of HA have been proposed to have pivotal roles in cell proliferation …
Hyaluronic acid for anticancer drug and nucleic acid delivery
Hyaluronic acid (HA) is widely used in anticancer drug delivery, since it is biocompatible,
biodegradable, non-toxic, and non-immunogenic; moreover, HA receptors are …
biodegradable, non-toxic, and non-immunogenic; moreover, HA receptors are …
Hydrogel scaffolds for differentiation of adipose-derived stem cells
Q Huang, Y Zou, MC Arno, S Chen, T Wang… - Chemical Society …, 2017 - pubs.rsc.org
Natural extracellular matrices (ECMs) have been widely used as a support for the adhesion,
migration, differentiation, and proliferation of adipose-derived stem cells (ADSCs). However …
migration, differentiation, and proliferation of adipose-derived stem cells (ADSCs). However …
Click hydrogels, microgels and nanogels: Emerging platforms for drug delivery and tissue engineering
Hydrogels, microgels and nanogels have emerged as versatile and viable platforms for
sustained protein release, targeted drug delivery, and tissue engineering due to excellent …
sustained protein release, targeted drug delivery, and tissue engineering due to excellent …
Bacterial Hyaluronidase Self-Triggered Prodrug Release for Chemo-Photothermal Synergistic Treatment of Bacterial Infection.
A novel platform for targeted on-demand prodrug ascorbic acid (AA) delivery is fabricated
using a bacterial hyaluronidase sensitive graphene-mesoporous silica nanosheet …
using a bacterial hyaluronidase sensitive graphene-mesoporous silica nanosheet …
Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated release
X Zhu, J Gu, Y Wang, B Li, Y Li, W Zhao… - Chemical …, 2014 - pubs.rsc.org
Zr-based MOF nanoparticles were applied as efficient carriers for alendronate delivery, and
an unprecedented drug loading capacity was achieved thanks to the inherent drug …
an unprecedented drug loading capacity was achieved thanks to the inherent drug …
[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting
KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …
Polylactide (PLA)-based amphiphilic block copolymers: synthesis, self-assembly, and biomedical applications
JK Oh - Soft Matter, 2011 - pubs.rsc.org
Polylactide (PLA) and its copolymers are one type of hydrophobic aliphatic polyester based
on hydroxyalkanoic acids. They possess exceptional qualities: biocompatibility; FDA …
on hydroxyalkanoic acids. They possess exceptional qualities: biocompatibility; FDA …
Fabrication of novel MXene (Ti 3 C 2)/polyacrylamide nanocomposite hydrogels with enhanced mechanical and drug release properties
P Zhang, XJ Yang, P Li, Y Zhao, QJ Niu - Soft Matter, 2020 - pubs.rsc.org
A highly stretchable nanocomposite (NC) hydrogel was fabricated via in situ free radical
polymerization of acrylamide. In particular, an exfoliated two-dimensional MXene (Ti3C2) …
polymerization of acrylamide. In particular, an exfoliated two-dimensional MXene (Ti3C2) …
Fully defined in situ cross-linkable alginate and hyaluronic acid hydrogels for myocardial tissue engineering
J Dahlmann, A Krause, L Möller, G Kensah, M Möwes… - Biomaterials, 2013 - Elsevier
Despite recent major advances including reprogramming and directed cardiac differentiation
of human cells, therapeutic application of in vitro engineered myocardial tissue is still not …
of human cells, therapeutic application of in vitro engineered myocardial tissue is still not …